Hirano S - Search Results

1

Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit V x 2 tumour model.

Okada M, Kudo S, Miyazaki O, Saino T, Ekimoto H, Iguchi H, Hirano S, Kuboki H, Kadosawa H, Takeuchi T. Okada M, et al. Among authors: hirano s. Br J Cancer. 1995 Mar;71(3):518-24. doi: 10.1038/bjc.1995.103. Br J Cancer. 1995. PMID: 7880733 Free PMC article.

2

Effects of pirarubicin in comparison with epirubicin and doxorubicin on the contractile function in rat isolated cardiac muscles.

Hirano S, Agata N, Iguchi H, Tone H. Hirano S, et al. Gen Pharmacol. 1995 Oct;26(6):1339-47. doi: 10.1016/0306-3623(94)00314-d. Gen Pharmacol. 1995. PMID: 7590129

3

Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.

Izumi H, Hirano S, Matsushita Y, Iguchi H, Tone H, Takeuchi T. Izumi H, et al. Among authors: hirano s. Cancer Biochem Biophys. 1994 Sep;14(2):137-49. Cancer Biochem Biophys. 1994. PMID: 7889494

4

Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia.

Agata N, Mase T, Izumi H, Hirano S, Iguchi H, Tone H, Takeuchi T. Agata N, et al. Among authors: hirano s. Cancer Biochem Biophys. 1995 Nov;15(2):95-101. Cancer Biochem Biophys. 1995. PMID: 8590441

5

Effects of pirarubicin, an antitumor antibiotic, on the cardiovascular system.

Hirano S, Agata N, Hara Y, Iguchi H, Shirai M, Tone H, Urakawa N. Hirano S, et al. Cancer Chemother Pharmacol. 1991;28(4):266-72. doi: 10.1007/BF00685533. Cancer Chemother Pharmacol. 1991. PMID: 1879043

6

Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.

Hirano S, Wakazono K, Agata N, Iguchi H, Tone H. Hirano S, et al. Drugs Exp Clin Res. 1994;20(4):153-60. Drugs Exp Clin Res. 1994. PMID: 7813387

7

Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.

Oikawa T, Sasaki M, Inose M, Shimamura M, Kuboki H, Hirano S, Kumagai H, Ishizuka M, Takeuchi T. Oikawa T, et al. Among authors: hirano s. Anticancer Res. 1997 May-Jun;17(3C):1881-6. Anticancer Res. 1997. PMID: 9216639

8

A possible mechanism of endothelium-dependent relaxation induced by pirarubicin and carbachol in rat isolated aorta.

Hirano S, Agata N, Hara Y, Iguchi H, Shirai M, Tone H, Urakawa N. Hirano S, et al. J Pharm Pharmacol. 1992 Mar;44(3):244-9. doi: 10.1111/j.2042-7158.1992.tb03591.x. J Pharm Pharmacol. 1992. PMID: 1354733

9

Pirarubicin-induced endothelium-dependent relaxation in rat isolated aorta.

Hirano S, Agata N, Hara Y, Iguchi H, Shirai M, Tone H, Urakawa N. Hirano S, et al. J Pharm Pharmacol. 1991 Dec;43(12):848-54. doi: 10.1111/j.2042-7158.1991.tb03193.x. J Pharm Pharmacol. 1991. PMID: 1687584

10

Synthesis and biological evaluation of cytogenin derivatives.

Matsumoto N, Nakashima T, Isshiki K, Kuboki H, Hirano SI, Kumagai H, Yoshioka T, Ishizuka M, Takeuchi T. Matsumoto N, et al. Among authors: hirano si. J Antibiot (Tokyo). 2001 Mar;54(3):285-96. doi: 10.7164/antibiotics.54.285. J Antibiot (Tokyo). 2001. PMID: 11372785 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,215 results

Search Page

Filters